ArticleCancer discovery2024

Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.

Douglas A Rubinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.